Abstracts tagged "OA and pain"

Abstract Number: 925 • 2014 ACR/ARHP Annual Meeting
Cortical Reorganization after Duloxetine Treatment-Related Pain Decrease in Knee Osteoarthritis
Pascal Tetreault¹, Marwan Baliki¹, Etienne Vachon-Presseau¹, Renita Evonne Yeasted², Thomas J. Schnitzer³ and A. Vania Apkarian^1,4, ¹Physiology, Northwestern University, Chicago, IL, ²PM&R, Northwestern University, Chicago, IL, ³PM&R and Int Med, Northwestern University, Chicago, IL, ⁴Anaesthesia and Surgery, Northwestern University, Chicago, IL
Background/Purpose: Structural brain properties of patients coping with chronic painful conditions are becoming better understood but knowledge on how pain treatment affects these properties is…
Abstract Number: 242 • 2014 ACR/ARHP Annual Meeting
WOMAC Pain Score Reflects Preceding Daily Pain Ratings in Knee Osteoarthritis Interventional Randomized Clinical Trials
Michael H. V. Nguyen¹, Renita Evonne Yeasted² and Thomas J. Schnitzer³, ¹University of Washington School of Medicine, Seattle, WA, ²PM&R, Northwestern University, Chicago, IL, ³PM&R and Int Med, Northwestern University, Chicago, IL
Background/Purpose The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) is a validated and widely used instrument for assessing osteoarthritis (OA) knee and hip pain,…
Abstract Number: 2131 • 2013 ACR/ARHP Annual Meeting
Osteoarthritis Pain: Variability and Clinical Correlations
Thomas J. Schnitzer¹, Renita Yeasted², Leijan Huang³, Jennifer Duffecy⁴, Mark Begale⁴ and A. Vania Apkarian³, ¹PM&R and Int Med, Northwestern University, Chicago, IL, ²PM&R, Northwestern University, Chicago, IL, ³Physiology, Northwestern University, Chicago, IL, ⁴Preventive Medicine, Northwestern University, Chicago, IL
Background/Purpose: Although osteoarthritis (OA) is an intensely studied model of chronic pain, little is known about the temporal dynamics of OA pain intensity and how…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].